Righton (Diagnostic Equipment) (SHG: 688217)

Righton is a corporation based in Shanghai, China. Established in 2012, the firm develops and provides diagnostic products and services for precision oncology, including tumor subtyping, MRD monitoring, and early cancer screening. It operates multiple technology platforms such as NGS, digital PCR, and flow cytometry, and manages subsidiaries across diagnostics, laboratory testing, and medical device development. The assets are managed by the executive management team.